Worldwide Over-the-Counter (OTC) Drug Market, The

Like this? Share it with your network

Share
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
1,364
On Slideshare
1,364
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
9
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1.    Get more info on this report!The Worldwide Over-the-Counter (OTC) Drug MarketMay 1, 2010Over-the-Counter (OTC) drugs are non-prescription drugs sold to consumers byconvenience and grocery stores. These drugs include pain relievers, cough and coldremedies, sleeping aids, antifungals, and other products approved for use as a self-medication product. There has been a particular focus in the pharmaceutical industry onOTC drugs, and in several market research reports over the past decade, KaloramaInformation has covered the strategies pharmaceutical companies are using in the OTCmarket. This report, The Worldwide Over the Counter (OTC) Drug Market has marketsizes and forecasts in five general segments: • Analgesics • Allergy, Cough, Cold, Flu Remedies • Gastrointestinal Remedies • Dermatologics • Others, including o Smoking Cessation Products o Sleep Aids o Hair Growth Remedies o Diet AidsRevenues for each segment were generated using dollar and unit sales for key productsin each segment and region. The report provides examples of OTC drugs in eachgeneral region, segmented as follows: • Asia Pacific and Africa • Europe • North America • South AmericaIssues and trends explored in this study include: • Mergers and Acquisitions • Distribution and Safety Issues • Consumer Advertising and Promotion • Demographics
  • 2. • World Health and Life Expectancy Trends • Prescription vs. OTC Industry • Rx-to-OTC Switch Industry • Economic Trends • Health Insurance Issues and Trends • Consumer Issues and Trends • Regulatory Environment • Access to MedicineThe report includes incidence of conditions which are often treated with OTC medicines,health statistics related to the industry, birth rates, world population, populations byregion and issues affecting the market as a whole. Information is presented as aworldwide overview, with special emphasis on the U.S., Japan, Germany, and other keymarkets. The market segments provide an overview of demographics, information aboutproducts available in each region, market estimates and forecasts. Additionally, acompetitive analysis of leading providers and profiles of providers is covered. In-depthprofiles are included for the following companies: • Bayer Consumer Health • Boehringer Ingelheim • GlaxoSmithKline • McNeil Consumer (Johnson & Johnson) • Merck/Schering-Plough • Novartis Pharmaceuticals • Pfizer/Wyeth Consumer • Procter & Gamble • Reckitt Benckiser • Sanofi-Aventis • Taisho Pharmaceutical • TakedaThe information for this report was gathered using both primary and secondary researchincluding comprehensive research of secondary sources such as company literature,databases, investment reports, and medical and business journals. Telephoneinterviews and email correspondence were the primary method of gathering information.For the purpose of this study, Kalorama Information conducted interviews with morethan 100 key industry officials, consultants, health care providers, and governmentpersonnel. These sources were the primary basis in gathering information specificallyrelating to revenue and market share data presented in this report. Additional interviewswere completed with relevant company representatives including marketing directors,division managers, and product representatives.All market data pertains to the world market at the manufacturers’ level. The base yearfor data was 2009. Historical data was provided for the years 2007 and 2008, withforecast data provided for 2010 through 2014. Compound annual growth rates (CAGRs)are provided for the 2007-2009 and 2009-2014 periods for each region and/or segment
  • 3. covered. Competitive analysis is provided for the year 2009. The forecasted marketanalysis for 2009-2014 was largely based on demographic trends, new developments,and global expansion.Table of ContentsCHAPTER ONE: EXECUTIVE SUMMARY • Background • Scope and Methodology • Size and Growth of the Market • Key Issues and Trends Affecting Market • Leading CompetitorsCHAPTER TWO: INTRODUCTION • Background • Distribution and Safety Issues in the United States • Consumer Advertising/Promotion • World Health and Life Expectancy o Life Expectancy o Birth Rates o Tobacco Use o Obesity • Declining Growth of the World Population • Prescription VS Over-the-Counter Industry • Rx-to-OTC Switch Industry • Rx-to-OTC Switch Forecast in the United States • Economic Trends • Purchasing Power Trends • U.S. Healthcare Market • U.S. Healthcare Challenges • Health Insurance Issues and Trends • Consumer Issues and Trends • U.S Consumers • Consumers around the World • Access to Professional Medical Services and the Link to Self-Medication • Regulatory Environment • Revisions to Pharmaceutical Affairs Law (PAL) in Japan • Russian Beneficiary Drug Provision Program • A Third Class of Drugs in the United StatesCHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA
  • 4. • Overview • Demographics • OTC Product Segments • Market Analysis • OTC Product Segment Market Analysis • Markets by CountryCHAPTER FOUR: OTC MARKETS IN EUROPE • Overview • Demographics • OTC Product Segments • Market Analysis o OTC Product Segment Market Analysis o Markets by CountryCHAPTER FIVE: OTC MARKETS IN NORTH AMERICA • Overview • Demographics • OTC Product Segments • Market Analysis • OTC Product Segment Market Analysis • Markets by CountryCHAPTER SIX: OTC MARKETS IN SOUTH AMERICA • Overview • Demographics • OTC Product Segments • Market Analysis • OTC Product Segment Market Analysis • Markets by CountryCHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS • Overview • OTC Product Segment Market Analysis • Markets by CountryCHAPTER EIGHT: LEADING OTC MANUFACTURERS • Overview • Competitor Analysis • Significant Mergers and Acquisitions o Sanofi-Aventis and Chattem Consumer
  • 5. o Schering-Plough and Merck & Co. o Wyeth and Pfizer o Bristol-Myers Squibb and Novartis AG o Johnson & Johnson and Pfizer o Bayer and Roche o Reckitt Benckiser and Adams Respiratory Therapeutics o Reckitt Benckiser and Boots Healthcare • Leading Corporate Profiles o Bayer Healthcare AG o Boehringer Ingelheim GMBH o Glaxo Smith Kline o Mc Neil Consumer o Merck/Schering-Plough o Novartis Consumer o Pfizer/Wyeth o Procter & Gamble o Reckitt Beckiser o Sanofi-Aventis/Chattem o Taisho Pharmaceutical o Takeda PharmaceuticalAPPENDIXLIST OF MAJOR COMPANIES LIST OF EXHIBITSCHAPTER ONE: EXECUTIVE SUMMARY • Table 1-1: Total World OTC Market Analysis, 2005-2014 • Figure 1-1: Total World OTC Market Analysis: 2005-2014CHAPTER TWO: INTRODUCTION • Table 2-1: Average Life Expectancy in Years by Country 1980, 2004 and 2009 • Table 2-2: Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010 • Figure 2-1: Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010 • Table 2-3: Percent of Smokers by Country • Figure 2-2: Average Percent of Smokers Worldwide in Developed Regions • Table 2-4: Percent of Obese* Population, 2006 • Table 2-5: World Population 1980 to 2050 • Figure 2-3: World Population 1980 to 2050 • Table 2-6: Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Country, 2009 • Figure 2-4: Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Country, 2009
  • 6. • Table 2-7: Leading FDA Approved Rx-to-OTC Switches, 1994-2009 • Figure 2-5: Number of New Rx-to-OTC Switches in the United States, per Year 1976-2009 • Table 2-8: Potential Rx-to-OTC Switches, 2010-2014 • Table 2-9: Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000 and 2006 • Figure 2-6: Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000, and 2006 • Table 2-10: Gross National Income Comparison by Country 2000-2005 • Figure 2-7: Gross National Income Growth by Country 2000-2005 • Table 2-11: National Healthcare Expenditures in the United States 1960-2015 • Figure 2-8: Healthcare Spending as a Percent of GDP in the United States • Table 2-12: Health Insurance Trends in the United States 2003-2007 • Figure 2-9: Typical Pharmacist-Consumer OTC Drug Counseling SessionCHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA • Table 3-1: Total Midyear Population by the Five Most Populated Countries in Asia-Pacific, 2005-2025 • Figure 3-1: Total Midyear Population by the Five Most Populated Countries in Asia-Pacific, 2005, 2015, and 2025 • Table 3-1: Total Midyear Population in Africa by Region, 1995-2025 • Figure 3-2: Total Midyear Population for Africa by Region, 2005, 2015, and 2025 • Table 3-6: Examples of Marketed OTC Products in Asia-Pacific and Africa (Product Name by Type and Marketer) • Table 3-7: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2009 and 2014 • Figure 3-5: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2009 • Figure 3-6: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2014 • Table 3-8: Asia-Pacific/Africa OTC Market Analysis, 2005-2014 • Figure 3-7: Asia-Pacific/Africa OTC Market Analysis: 2005-2014 • Table 3-10: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2005- 2014 • Figure 3-8: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2005- 2014 • Figure 3-9: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2009 • Table 3-12: Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2009 • Figure 3-10: Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2009CHAPTER FOUR: OTC MARKETS IN EUROPE • Table 4-1: Total Midyear Population by the Five Most Populated Countries in Europe, 2005-2009
  • 7. • Figure 3-1: Total Midyear Population by the Five Most Populated Countries in Europe, 2005, 2015, and 2025 • Table 4-4: Examples of Marketed OTC Products in Europe (Product Name by Type and Marketer) • Table 4-5: European OTC Market as a Percentage of World Market, 2009 and 2014 • Figure 4-3: European OTC Market as a Percentage of World Market, 2009 • Figure 4-4: European OTC Market as a Percentage of World Market, 2014 • Table 4-6: European OTC Market Analysis, 2005-2014 • Figure 4-5: European OTC Market Analysis: 2005-2014 • Table 4-8: European OTC Market Analysis, Markets by Product Segment, 2005- 2014 • Figure 4-6: European OTC Market Analysis, Markets by Product Segment, 2005- 2014 • Figure 4-7: European OTC Market Analysis by Product Segment, 2009 • Table 4-10: European OTC Market Analysis by Selected Country, 2009 • Figure 4-8: European OTC Market Analysis by Selected Country, 2009CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA • Table 5-1: Total Midyear Population by the Five Most Populated Countries in North America, 2005-2025 • Figure 5-1: Total Midyear Population by the Five Most Populated Countries in North America, 2005, 2015, and 2025 • Table 5-4: Examples of Marketed OTC Products in North America (Product Name by Type and Marketer • Table 5-5: North American OTC Market as a Percentage of World Market, 2009 and 2014 • Figure 5-3: North American OTC Market as a Percentage of World Market, 2009 • Figure 5-4: North American OTC Market as a Percentage of World Market, 2014 • Table 5-6: North American OTC Market Analysis, 2005-2014 • Figure 5-5: North American OTC Market Analysis: 2005-2014 • Table 5-8: North American OTC Market Analysis by Product Segment, 2005- 2014 • Figure 5-6: North American OTC Market Analysis by Product Segment, 2005- 2014 • Figure 5-7: North American OTC Market Analysis by Product Segment, 2009 • Table 5-10: North American OTC Market Analysis by Selected Country, 2009 • Figure 5-8: North American OTC Market Analysis by Selected Country, 2009CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA • Table 6-1: Total Midyear Population by the Five Most Populated Countries in South America, 2005-2025 • Figure 6-1: Total Midyear Population by the Five Most Populated Countries in South America, 2005, 2015, and 2025
  • 8. • Table 6-4: Examples of Marketed OTC Products in South America (Product Name by Type and Marketer) • Table 6-5: South American OTC Market as a Percentage of World Market, 2009 and 2014 • Figure 6-3: South American OTC Market as a Percentage of World Market, 2009 • Figure 6-4: South American OTC Market as a Percentage of World Market, 2014 • Table 6-6: South American OTC Market Analysis, 2005-2014 • Figure 6-5: South American OTC Market Analysis: 2005-2014 • Table 6-8: South American OTC Market Analysis by Product Segment, 2005- 2014 • Figure 6-6: South American OTC Market Analysis by Product Segment, 2005- 2014 • Figure 6-7: South American OTC Market Analysis by Product Segment, 2009 • Table 6-10: South American OTC Market Analysis by Selected Country, 2009 • Figure 6-8: South American OTC Market Analysis by Selected Country, 2009CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS • Table 7-1: Total World OTC Market Analysis, 2005-2014 • Figure 7-1: Total World OTC Market Analysis: 2005-2014 • Table 7-3: Total World OTC Market Analysis, Markets by Product Segment, 2005-2014 • Figure 7-2: Total World OTC Market Analysis, Markets by Product Segment, 2005-2014 • Figure 7-3: Total World OTC Market Analysis by Product Segment, 2009 • Figure 7-4: Total World OTC Market Analysis by Product Segment, 2014 • Table 7-5: Top Ten World OTC Markets by Country, 2009 • Figure 7-5: Top Ten World OTC Markets by Country, 2009CHAPTER EIGHT: LEADING OTC MANUFACTURERS • Table 8-1: Leading Suppliers Shares of the OTC Market by Estimated Revenues—2007, 2008, and 2009 • Figure 8-1: Leading Suppliers Shares of the OTC Market, 2007 • Figure 8-2: Leading Suppliers Shares of the OTC Market, 2008 • Figure 8-3: Leading Suppliers Shares of the OTC Market, 2009Available immediately for Online Download athttp://www.marketresearch.com/product/display.asp?productid=2661910  
  • 9. US: 800.298.5699UK +44.207.256.3920Intl: +1.240.747.3093Fax: 240.747.3004